Prosecution Insights
Last updated: August 18, 2026

Examiner: LEE, ANDREW ELDRIDGE

Tech Center 3600 • Art Units: 3626 3684

This examiner grants 17% of resolved cases

Performance Statistics

17.0%
Allow Rate
-35.0% vs TC avg
178
Total Applications
+32.0%
Interview Lift
1394
Avg Prosecution Days
Based on 135 resolved cases, 2023–2026

Rejection Statute Breakdown

36.9%
§101 Eligibility
10.2%
§102 Novelty
39.6%
§103 Obviousness
10.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18986980 GENERATING AND DISPLAYING INFORMATION RELATED TO DEVIATIONS FROM PAST PREOPERATIVE SURGICAL PLANS WITHIN GRAPHICAL USER INTERFACES OF A SURGICAL PLANNING SYSTEM Final Rejection ARTHREX, INC.
18648288 METHODS AND SYSTEMS FOR ASSESSING HEMORRHOIDS AND TREATMENT EFFECTIVENESS THEREOF Final Rejection Citius Pharmaceuticals, Inc.
18846553 DETERMINING A PATIENT’S RESPONSE TO A TREATMENT IN MULTIPLE MYELOMA Final Rejection Genentech, Inc.
18908559 MULTIDIMENSIONAL OPTICAL TISSUE CLASSIFICATION AND DISPLAY Non-Final OA OHIO STATE INNOVATION FOUNDATION
18162296 SYSTEMS AND METHODS FOR PRESCRIPTION PRICE COMPARISON ACROSS PROCESSORS Final Rejection OPTUM, INC.
18619114 DATA PROCESSING SYSTEMS AND METHODS FOR IDENTIFYING NEW INDICATIONS FOR DRUGS Final Rejection Sanofi

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month